Bristol Myers Squibb Stock Hits Day High with Strong Intraday Performance

Bristol Myers Squibb Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable uptick in its stock price, gaining 3.06% on July 13, 2026. The stock reached an intraday high of USD 59.44, reflecting a strong performance relative to the broader market, as the S&P 500 declined by 0.79% on the same day. Over the past week, Bristol Myers Squibb has shown a robust 4.66% increase, while its one-month performance stands at 3.87%. Year-to-date, the stock has risen by 10.01%, outpacing the S&P 500's 9.79% gain. Despite a challenging three-year performance, where the stock has declined by 4.72%, it has demonstrated resilience with a 26.63% increase over the past year. Key financial metrics highlight the company's solid position, with net sales growing at an annual rate of 6.47% and operating profit at 23.31%. The company reported its highest operating cash flow at USD 15,901 million and a return on capital employed (ROCE) of 29.31%. With a market capitalization of USD 160,369 million, Bristol Myers Squibb continues to navigate the competitive landscape of the pharmaceutical industry.